
|Articles|May 15, 2002
Beware of pitfalls in assessing glaucoma drug results
In our clinics we face practical decisions every day. Multiple competing drugs are often available for any particular problem. Glaucoma treatment options are especially numerous. A little math can easily demonstrate the complexity of glaucoma treatment options.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5






















